Navigation Links
Rigel Announces Second Quarter 2013 Financial Results
Date:8/6/2013

rd-looking" statements, including, without limitation, statements related to the further development of certain drug candidates, including to the future plans with respect to fostamatanib and the timing of announcement of those plans and the results of certain studies, and the sufficiency of our funds and the timing of our cash.  Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "planned," "will," "expect," and similar expressions are intended to identify these forward-looking statements.  These forward-looking statements are based on Rigel's current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the availability of resources to develop Rigel's product candidates and our need for additional capital in the future to sufficiently fund our operations and research, the uncertain timing of completion of and the success of clinical trials and the potential problems that may arise in the clinical development process, and that our corporate collaborations or license agreements may be unsuccessful, market competition, risks associated with and Rigel's dependence on Rigel's corporate partnerships, as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the three months ended March 31, 2013. Rigel does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein.

 

Contact: Ryan D. Maynard
Phone: 650.624.1284'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Rigel Announces Third Quarter 2012 Financial Results
7. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
8. Rigel to Present at BIO CEO & Investor Conference
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
11. Rigel Announces First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... PARK, Calif. , July 28, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based ... announced the publication of the SENZA-RCT results in ... official Journal of the American Society of Anesthesiologists. ... a ground-breaking study that was the first to ...
(Date:7/28/2015)... -- The Physician-Patient Alliance for Health & Safety (PPAHS) ... Your Hospital Stay ." "Help us ensure ... these patients went home from hospital," said Michael ... to the patient stories presented at the ... Continuous Monitoring of Patients on Opioids (shown above). ...
(Date:7/28/2015)... DUBLIN , July 28, 2015 ... the addition of the "Global Hearing Aids ... The global hearing aids market to ... period 2014-2019. Factors such as ... are driving market growth. The market has witnessed ...
Breaking Medicine Technology:Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2
... , ... of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, ... biotech lab systems executive with more than 30 years ... Mr. Goldstein will direct Microchip Biotechnologies, marketing, business development, ...
... , , CAMBRIDGE, Mass. and TOKYO, ... Ltd. announced today the further extension of their research ... increases the collaboration term to seven years and brings ... The companies have been working together since January 2005 ...
Cached Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment (MMT) ... group was more likely to relapse to opiate use (1) and more likely ...
(Date:7/28/2015)... ... 2015 , ... The Denver Foundation and Blair-Caldwell African American ... a photographic and narrative exploration of African American giving, which runs August 1-31 ... Denver is one of only ten cities to host “The Soul of Philanthropy ...
(Date:7/28/2015)... ... 2015 , ... Dr. Edward Buckingham and Buckingham Center for Facial ... 2016. Coming to Austin from Philadelphia, Dr. Roy will be completing his Fellowship ... is facilitated annually by the American Academy of Facial Plastic and Reconstructive Surgery. ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Obama’s visit to Ethiopia to learn more about the impact of U.S. collaborations ... This initiative focuses on accelerating agricultural development as an engine of broad-based economic ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... embedded building blocks for edge devices that enable the Internet of Things (IoT), ... Intel® Core™ i7/i5 processor to provide exceptional computing power and multitasking capabilities. The ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3
... and, according to a study by researchers at the University ... increased risk of developing open-angle glaucoma (OAG). Joshua D. ... research team that recently reviewed billing records of more than ... in a managed care network in the United States and ...
... NEW YORK, NY, LA JOLLA and SOUTH SAN FRANCISCO, CA, ... at and associated with the International AIDS Vaccine Initiative (IAVI), ... Monogram Biosciences Inc., a LabCorp company, report in the current ... antibodies capable of neutralizing a broad spectrum of variants of ...
... (HealthDay News) -- People with rheumatoid arthritis (RA) are ... other cardiovascular events due to RA-related inflammation and other ... found that treating RA inflammation with disease-modifying anti-rheumatic drugs ... the risk. The study included more than 400 ...
... , WEDNESDAY, Aug. 17 (HealthDay News) -- ... than one-third of lower leg injuries treated in U.S. ... Alternative approaches to treatment, such as an emergency hotline ... emergency department resources, researchers from Massachusetts General Hospital in ...
... Researchers at Rhode Island Hospital,s Alzheimer,s Disease and ... oil supplements and cognitive functioning as well as differences ... oil supplements. The findings suggest possible benefits of fish ... were reported at the recent International Conference on Alzheimer,s ...
... cancer patients go for care plays a large role in ... the University of Michigan Comprehensive Cancer Center finds. While ... role in treatment, researchers found unexplained hospital factors had a ... go to makes a difference in use of radioactive iodine. ...
Cached Medicine News:Health News:Study focuses on relationship between glaucoma and diabetes, hypertension 2Health News:AIDS researchers isolate new potent and broadly effective antibodies against HIV 2Health News:AIDS researchers isolate new potent and broadly effective antibodies against HIV 3Health News:AIDS researchers isolate new potent and broadly effective antibodies against HIV 4Health News:Inflammation From Rheumatoid Arthritis Tied to Heart Disease 2Health News:Sprained Ankles Straining ER Resources, Study Finds 2Health News:Rhode Island Hospital study identifies fish oil's impact on cognition and brain structure 2Health News:Thyroid cancer treatment varies by hospital, U-M study finds 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: